 Charles Glasier
Concepts (211)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain | 16 | 2023 | 1337 | 1.410 |
Why?
| | Magnetic Resonance Imaging | 22 | 2025 | 1507 | 1.400 |
Why?
| | Tomography, X-Ray Computed | 6 | 2021 | 1140 | 0.970 |
Why?
| | Radiation Dosage | 5 | 2021 | 160 | 0.850 |
Why?
| | Optic Nerve | 4 | 2024 | 39 | 0.620 |
Why?
| | Sturge-Weber Syndrome | 1 | 2017 | 11 | 0.540 |
Why?
| | Hypopituitarism | 2 | 2014 | 16 | 0.530 |
Why?
| | Eye Abnormalities | 2 | 2014 | 24 | 0.520 |
Why?
| | Pituitary Gland | 2 | 2014 | 87 | 0.500 |
Why?
| | Diffusion Tensor Imaging | 7 | 2023 | 102 | 0.490 |
Why?
| | Hematoma, Epidural, Cranial | 1 | 2015 | 6 | 0.480 |
Why?
| | Sinus Thrombosis, Intracranial | 1 | 2015 | 17 | 0.470 |
Why?
| | Phlebography | 1 | 2015 | 54 | 0.460 |
Why?
| | Intracranial Hemorrhages | 1 | 2015 | 43 | 0.460 |
Why?
| | Magnetic Resonance Angiography | 1 | 2015 | 67 | 0.460 |
Why?
| | Brain Injuries | 4 | 2023 | 158 | 0.460 |
Why?
| | Child | 22 | 2024 | 7194 | 0.460 |
Why?
| | Neuroimaging | 1 | 2015 | 91 | 0.450 |
Why?
| | Aicardi Syndrome | 1 | 2014 | 3 | 0.440 |
Why?
| | Ketones | 1 | 2014 | 10 | 0.440 |
Why?
| | Spasms, Infantile | 1 | 2014 | 31 | 0.420 |
Why?
| | Brain Diseases | 3 | 2013 | 80 | 0.410 |
Why?
| | Child, Preschool | 16 | 2023 | 4046 | 0.380 |
Why?
| | Infant, Newborn | 13 | 2025 | 2871 | 0.370 |
Why?
| | Spinal Dysraphism | 1 | 2011 | 39 | 0.360 |
Why?
| | Attention | 1 | 2011 | 168 | 0.340 |
Why?
| | Anxiety | 2 | 2025 | 305 | 0.320 |
Why?
| | Diffusion Magnetic Resonance Imaging | 3 | 2022 | 131 | 0.320 |
Why?
| | Humans | 40 | 2025 | 52441 | 0.320 |
Why?
| | Infant | 12 | 2023 | 3709 | 0.310 |
Why?
| | Demyelinating Diseases | 1 | 2008 | 7 | 0.290 |
Why?
| | Female | 25 | 2025 | 28277 | 0.280 |
Why?
| | Neurodegenerative Diseases | 1 | 2008 | 83 | 0.260 |
Why?
| | Optic Nerve Diseases | 2 | 2008 | 21 | 0.250 |
Why?
| | Ocular Motility Disorders | 2 | 2007 | 16 | 0.250 |
Why?
| | Male | 22 | 2025 | 26874 | 0.240 |
Why?
| | Amygdala | 1 | 2025 | 36 | 0.220 |
Why?
| | Brain Mapping | 4 | 2021 | 221 | 0.210 |
Why?
| | Wounds and Injuries | 2 | 2017 | 300 | 0.210 |
Why?
| | Sodium, Dietary | 1 | 2023 | 24 | 0.200 |
Why?
| | Diagnosis, Differential | 6 | 2015 | 1028 | 0.200 |
Why?
| | Strabismus | 2 | 2008 | 14 | 0.200 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2025 | 196 | 0.190 |
Why?
| | Craniocerebral Trauma | 1 | 2023 | 63 | 0.190 |
Why?
| | Trauma Centers | 3 | 2018 | 209 | 0.190 |
Why?
| | Visual Cortex | 1 | 2002 | 10 | 0.190 |
Why?
| | Blindness, Cortical | 1 | 2002 | 3 | 0.180 |
Why?
| | Visual Pathways | 1 | 2002 | 11 | 0.180 |
Why?
| | Depressive Disorder, Major | 1 | 2023 | 148 | 0.180 |
Why?
| | Cognition | 2 | 2022 | 363 | 0.180 |
Why?
| | Optic Disk | 1 | 2002 | 20 | 0.180 |
Why?
| | Mothers | 2 | 2023 | 262 | 0.180 |
Why?
| | Meningitis, Haemophilus | 1 | 2021 | 7 | 0.170 |
Why?
| | Child Abuse | 1 | 2023 | 143 | 0.170 |
Why?
| | Vasospasm, Intracranial | 1 | 2021 | 14 | 0.170 |
Why?
| | Adolescent | 9 | 2017 | 6713 | 0.160 |
Why?
| | Pregnancy Complications | 1 | 2025 | 399 | 0.160 |
Why?
| | Depression | 2 | 2023 | 603 | 0.150 |
Why?
| | Cross-Sectional Studies | 4 | 2017 | 1677 | 0.140 |
Why?
| | Heart Defects, Congenital | 2 | 2015 | 615 | 0.140 |
Why?
| | Sepsis | 1 | 2021 | 236 | 0.140 |
Why?
| | Sensitivity and Specificity | 3 | 2015 | 871 | 0.140 |
Why?
| | Meninges | 1 | 2017 | 15 | 0.140 |
Why?
| | Retrospective Studies | 7 | 2023 | 6694 | 0.130 |
Why?
| | Registries | 2 | 2017 | 638 | 0.130 |
Why?
| | Pregnancy | 4 | 2025 | 2642 | 0.120 |
Why?
| | Cerebral Ventriculography | 1 | 2015 | 3 | 0.120 |
Why?
| | False Positive Reactions | 1 | 2015 | 64 | 0.120 |
Why?
| | Cerebral Ventricles | 1 | 2015 | 23 | 0.120 |
Why?
| | Cerebrospinal Fluid Shunts | 1 | 2015 | 19 | 0.120 |
Why?
| | Hydrocephalus | 1 | 2015 | 41 | 0.110 |
Why?
| | Reproducibility of Results | 2 | 2015 | 1223 | 0.110 |
Why?
| | Internet | 1 | 2016 | 262 | 0.110 |
Why?
| | Hypercapnia | 1 | 2014 | 16 | 0.110 |
Why?
| | Anti-Inflammatory Agents | 2 | 2012 | 166 | 0.110 |
Why?
| | Hypoxia-Ischemia, Brain | 1 | 2015 | 64 | 0.110 |
Why?
| | Prospective Studies | 4 | 2025 | 2433 | 0.110 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2012 | 234 | 0.100 |
Why?
| | Young Adult | 4 | 2019 | 4346 | 0.100 |
Why?
| | Migraine with Aura | 1 | 2012 | 4 | 0.100 |
Why?
| | Brain Edema | 1 | 2012 | 37 | 0.090 |
Why?
| | Pediatrics | 1 | 2015 | 302 | 0.090 |
Why?
| | Task Performance and Analysis | 1 | 2011 | 52 | 0.090 |
Why?
| | Cardiopulmonary Bypass | 1 | 2012 | 93 | 0.090 |
Why?
| | Ketamine | 1 | 2012 | 61 | 0.090 |
Why?
| | Heart Septal Defects, Ventricular | 1 | 2012 | 46 | 0.090 |
Why?
| | Carotid Artery, Internal, Dissection | 1 | 2011 | 8 | 0.090 |
Why?
| | Cavernous Sinus | 1 | 2011 | 15 | 0.090 |
Why?
| | Heart Diseases | 1 | 2014 | 217 | 0.090 |
Why?
| | Respiration, Artificial | 1 | 2014 | 288 | 0.090 |
Why?
| | Meningomyelocele | 1 | 2011 | 19 | 0.090 |
Why?
| | Neuroprotective Agents | 1 | 2012 | 103 | 0.090 |
Why?
| | Arnold-Chiari Malformation | 1 | 2011 | 18 | 0.090 |
Why?
| | Intracranial Aneurysm | 1 | 2011 | 46 | 0.090 |
Why?
| | Tuberous Sclerosis | 1 | 2011 | 37 | 0.090 |
Why?
| | Executive Function | 1 | 2011 | 85 | 0.090 |
Why?
| | Prenatal Diagnosis | 2 | 2024 | 97 | 0.080 |
Why?
| | Imaging, Three-Dimensional | 1 | 2011 | 150 | 0.080 |
Why?
| | Spinal Nerve Roots | 1 | 2010 | 12 | 0.080 |
Why?
| | Guillain-Barre Syndrome | 1 | 2010 | 13 | 0.080 |
Why?
| | Rhabdoid Tumor | 1 | 2009 | 13 | 0.080 |
Why?
| | Meningeal Neoplasms | 1 | 2009 | 51 | 0.080 |
Why?
| | Central Nervous System Neoplasms | 1 | 2009 | 69 | 0.070 |
Why?
| | Anisotropy | 2 | 2022 | 60 | 0.070 |
Why?
| | Receptors, Somatostatin | 1 | 2008 | 3 | 0.070 |
Why?
| | Rhombencephalon | 1 | 2007 | 4 | 0.070 |
Why?
| | Mitochondrial Diseases | 1 | 2008 | 44 | 0.070 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2008 | 50 | 0.070 |
Why?
| | Inflammation | 1 | 2012 | 649 | 0.070 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2008 | 249 | 0.070 |
Why?
| | Cerebellum | 1 | 2007 | 129 | 0.060 |
Why?
| | Preoperative Care | 2 | 2021 | 173 | 0.060 |
Why?
| | Injury Severity Score | 2 | 2017 | 165 | 0.060 |
Why?
| | Treatment Outcome | 2 | 2014 | 5508 | 0.060 |
Why?
| | Adult | 6 | 2025 | 14205 | 0.060 |
Why?
| | Electroencephalography | 3 | 2015 | 301 | 0.060 |
Why?
| | Connectome | 1 | 2025 | 25 | 0.060 |
Why?
| | Child Development | 2 | 2020 | 208 | 0.060 |
Why?
| | Neural Pathways | 1 | 2025 | 94 | 0.050 |
Why?
| | Subarachnoid Space | 1 | 2024 | 2 | 0.050 |
Why?
| | Brain Neoplasms | 1 | 2008 | 302 | 0.050 |
Why?
| | Neuronal Ceroid-Lipofuscinoses | 1 | 2004 | 6 | 0.050 |
Why?
| | Chromosomes, Human, Pair 15 | 1 | 2004 | 9 | 0.050 |
Why?
| | Visual Acuity | 2 | 2003 | 144 | 0.050 |
Why?
| | Nerve Net | 1 | 2025 | 76 | 0.050 |
Why?
| | Retinal Degeneration | 1 | 2004 | 9 | 0.050 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2008 | 639 | 0.050 |
Why?
| | Exons | 1 | 2004 | 101 | 0.050 |
Why?
| | Syndrome | 1 | 2024 | 247 | 0.050 |
Why?
| | Molecular Chaperones | 1 | 2004 | 76 | 0.050 |
Why?
| | Hematoma, Subdural | 1 | 2023 | 13 | 0.050 |
Why?
| | Optic Chiasm | 1 | 2003 | 6 | 0.050 |
Why?
| | Optic Atrophy, Hereditary, Leber | 1 | 2003 | 5 | 0.050 |
Why?
| | Retinal Hemorrhage | 1 | 2023 | 15 | 0.050 |
Why?
| | Chromosome Deletion | 1 | 2004 | 138 | 0.050 |
Why?
| | Abnormalities, Multiple | 1 | 2024 | 164 | 0.050 |
Why?
| | Membrane Glycoproteins | 1 | 2004 | 239 | 0.050 |
Why?
| | Longitudinal Studies | 1 | 2025 | 756 | 0.050 |
Why?
| | Haemophilus influenzae | 1 | 2021 | 17 | 0.040 |
Why?
| | Ventriculoperitoneal Shunt | 1 | 2021 | 28 | 0.040 |
Why?
| | Pilot Projects | 2 | 2014 | 725 | 0.040 |
Why?
| | Language | 1 | 2021 | 142 | 0.040 |
Why?
| | Functional Laterality | 2 | 2012 | 91 | 0.040 |
Why?
| | Diet | 1 | 2023 | 591 | 0.040 |
Why?
| | Arkansas | 2 | 2016 | 2013 | 0.040 |
Why?
| | Infant, Premature | 1 | 2002 | 327 | 0.040 |
Why?
| | Neurologic Examination | 2 | 2012 | 73 | 0.040 |
Why?
| | Fetal Diseases | 1 | 2018 | 54 | 0.030 |
Why?
| | Crohn Disease | 1 | 2018 | 115 | 0.030 |
Why?
| | Attitude to Health | 1 | 2018 | 191 | 0.030 |
Why?
| | Body Burden | 1 | 2016 | 11 | 0.030 |
Why?
| | Electroretinography | 2 | 2008 | 17 | 0.030 |
Why?
| | Retreatment | 1 | 2016 | 58 | 0.030 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 2016 | 37 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2018 | 390 | 0.030 |
Why?
| | Demography | 1 | 2016 | 92 | 0.030 |
Why?
| | Hospitals, Pediatric | 1 | 2017 | 241 | 0.030 |
Why?
| | Patient Transfer | 1 | 2016 | 99 | 0.030 |
Why?
| | Polymerase Chain Reaction | 2 | 2008 | 458 | 0.030 |
Why?
| | DNA, Mitochondrial | 2 | 2008 | 112 | 0.030 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2014 | 25 | 0.030 |
Why?
| | Infant, Extremely Low Birth Weight | 1 | 2014 | 29 | 0.030 |
Why?
| | Ophthalmoscopy | 1 | 2013 | 17 | 0.030 |
Why?
| | Verapamil | 1 | 2012 | 19 | 0.020 |
Why?
| | Methylprednisolone | 1 | 2012 | 40 | 0.020 |
Why?
| | Calcium Channels | 1 | 2012 | 42 | 0.020 |
Why?
| | Intention to Treat Analysis | 1 | 2012 | 30 | 0.020 |
Why?
| | Developmental Disabilities | 1 | 2013 | 125 | 0.020 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 2012 | 59 | 0.020 |
Why?
| | Calcium Channel Blockers | 1 | 2012 | 60 | 0.020 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2012 | 51 | 0.020 |
Why?
| | Injections, Intravenous | 1 | 2012 | 130 | 0.020 |
Why?
| | Gait Disorders, Neurologic | 1 | 2012 | 37 | 0.020 |
Why?
| | Risk Assessment | 1 | 2016 | 1349 | 0.020 |
Why?
| | Central Nervous System | 1 | 2012 | 83 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2012 | 370 | 0.020 |
Why?
| | Reference Standards | 1 | 2011 | 51 | 0.020 |
Why?
| | Linear Models | 1 | 2012 | 288 | 0.020 |
Why?
| | C-Reactive Protein | 1 | 2012 | 151 | 0.020 |
Why?
| | Cognition Disorders | 1 | 2012 | 213 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2012 | 726 | 0.020 |
Why?
| | Prevalence | 1 | 2013 | 1016 | 0.020 |
Why?
| | Chromosomes, Human, Pair 22 | 1 | 2009 | 38 | 0.020 |
Why?
| | Cardiac Surgical Procedures | 1 | 2013 | 329 | 0.020 |
Why?
| | Lumbar Vertebrae | 1 | 2010 | 99 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2013 | 1045 | 0.020 |
Why?
| | DNA | 1 | 2012 | 544 | 0.020 |
Why?
| | Cytokines | 1 | 2012 | 622 | 0.020 |
Why?
| | Nystagmus, Pathologic | 1 | 2008 | 3 | 0.020 |
Why?
| | GTP Phosphohydrolases | 1 | 2008 | 29 | 0.020 |
Why?
| | Indium Radioisotopes | 1 | 2008 | 2 | 0.020 |
Why?
| | Somatostatin | 1 | 2008 | 28 | 0.020 |
Why?
| | Neoplasms | 1 | 2018 | 1314 | 0.020 |
Why?
| | Vision Disorders | 1 | 2008 | 61 | 0.020 |
Why?
| | Cranial Irradiation | 1 | 2008 | 24 | 0.020 |
Why?
| | Prognosis | 1 | 2013 | 2100 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2013 | 2294 | 0.020 |
Why?
| | Time Factors | 1 | 2013 | 2987 | 0.020 |
Why?
| | Radiation Injuries | 1 | 2008 | 114 | 0.020 |
Why?
| | Proteins | 1 | 2008 | 353 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2008 | 938 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2008 | 1202 | 0.010 |
Why?
| | Risk Factors | 1 | 2013 | 3971 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 2004 | 62 | 0.010 |
Why?
| | Hypertrophy | 1 | 2003 | 53 | 0.010 |
Why?
| | Alleles | 1 | 2004 | 279 | 0.010 |
Why?
| | DNA Mutational Analysis | 1 | 2003 | 179 | 0.010 |
Why?
| | Biopsy | 1 | 2004 | 594 | 0.010 |
Why?
| | Skin | 1 | 2004 | 416 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 2004 | 799 | 0.010 |
Why?
| | Middle Aged | 1 | 2008 | 13133 | 0.010 |
Why?
|
|
Glasier's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|